Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07283757 · ClinicalTrials.gov registry record · NA
PTSD Treatment for Incarcerated Men and Women: AV
A NA study of PTSD, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- NA
- Development phase
- 900
- Enrollment target
- 1
- Study location
NCT07283757: Recruiting NA study of PTSD, sponsored by University of Wisconsin, Madison.
NCT07283757 is a NA study of PTSD that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 900 participants, above the 296-participant average among 154 other PTSD trials with a reported enrollment target (204% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07283757, a NA study of PTSD, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- NA
- Development phase
- 900 participants
- Enrollment target
- 1
- Study location
Study Summary
This research will help identify if a PTSD treatment group, called Cognitive Processing Therapy (CPT), that is used in community settings is helpful in reducing PTSD symptoms among people who are incarcerated. The goal of CPT is to create a space for people to modify unhelpful beliefs related to trauma. A total of 692 participants will be enrolled from 6 locations and can expects to be on study for up to 24 weeks.
Primary Outcome
Effectiveness of group CPT in reducing conduct reports measured by number of violations of prison rules such assaults and substance use.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Processing Therapy
Study Locations (1)
Wisconsin
- Psychiatric Institute and Clinic - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2025-12-22 |
| Est. Completion | 2029-12 |
| Phase | NA |
What NCT07283757 shows while recruiting
NCT07283757 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, above the 296-participant average among 154 other PTSD trials with a reported enrollment target (204% higher).
The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Processing Therapy is the first listed.
NCT07283757 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT07283757 about?
NCT07283757 is a clinical study titled "PTSD Treatment for Incarcerated Men and Women: AV". This research will help identify if a PTSD treatment group, called Cognitive Processing Therapy (CPT), that is used in community settings is helpful in reducing PTSD symptoms among people who are incarcerated. The goal of CPT is to create a space for people to modify unhelpful beliefs related to tra...
What is the current status of trial NCT07283757?
This trial is currently recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2025-12-22. Estimated completion is 2029-12.
What conditions does trial NCT07283757 study?
This clinical trial studies the following conditions: PTSD.
What interventions are being tested in trial NCT07283757?
The interventions under investigation include: Cognitive Processing Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT07283757?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07283757 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07283757's enrollment target sits among peer trials
900 5th of 154 higher than 150 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
RECRUITING · NA
-
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02670408 · 900 participants
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
- NCT02960022 · 900 participants · Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI